Trial Profile
A Multi-Center Clinical Study to Evaluate the Safety and Efficacy of Folatescan (Technetium Tc 99m Ec20) in Patients with suspected ovarian carcinoma or Recurrent Endometrial Carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Technetium Tc99m etarfolatide (Primary) ; Folic acid
- Indications Endometrial cancer; Ovarian cancer
- Focus Diagnostic use
- Sponsors Endocyte
- 27 Apr 2015 New trial record